View in EDS PDF Full Text

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.

Saved in:
Bibliographic Details
Title: MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.
Authors: Nagy, E1, Gajjar, K B2, Patel, I I3, Taylor, S4, Martin-Hirsch, P L5, Stringfellow, H F6, Martin, F L2, Phillips, D H1
Source: British Journal of Cancer. 6/10/2014, Vol. 110 Issue 12, p2874-2880. 7p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/bjc.2014.263